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ABSTRACT An antibody (lgG1) was designed for oriented adherence to a metal-containing surface. This was achieved by adding a
metal-chelating peptide, (CP = His-Trp-His-His-His-Pro), to the COOH-terminus of the heavy chain through genetic engineering. Electro-
poration of the engineered heavy chain gene into cells expressing the complimentary light chain yielded colonies secreting an intact
antibody containing the metal-chelating peptide (IgG,-CP) which had high affinity for a nickel-loaded iminodiacetate column. Purified
IgG1-CP was bound to nickel-treated mica and imaged by atomic force microscopy (AFM). Antibody lacking the COOH-terminal metal
binding peptide failed to produce discernible AFM images. The AFM images of individual IgG1-CP molecules and their calculated
dimensions demonstrated that regiospecific binding and uniform orientation of the antibody was imparted by the peptide. The ability to
stably orient macromolecules in their native state to a surface may be used advantageously to visualize them.
INTRODUCTION
Atomic Force Microscopy (AFM) is a highly useful tool
for visualizing the three-dimensional structures of pro-
teins and polynucleotides. AFM and similar atomic-
scale visualization instruments, such as the Scanning
Tunneling Microscope (STM), are serving as prototypes
for the development of tools to not only visualize, but
eventually to manipulate individual molecules and
atoms (1).
In order to utilize these instruments, it is necessary to
immobilize the molecules to be visualized or manipu-
lated so that the mechanical forces involved in the proce-
dure do not physically remove the molecules from the
surface of the AFM substrate. Attachment of molecules
to a substrate for observation or manipulation under na-
tive conditions has proven difficult. For example, to
image plasmid DNA, Hansma et al. (2) found it neces-
sary to alcohol-precipitate the DNA onto the AFM sub-
strate, to prevent its movement by the AFM cantilever
tip. Similarly, Lin et al. (3), described the imaging ofIgG
molecules by AFM, but they could not achieve adher-
ence of the proteins to the surface without forming "lat-
eral interactions" among the molecules. As a result, a
random latticework of IgG molecules formed and indi-
vidual protein molecules were desorbed from the AFM
substrate. Weisenhorn et al. (4), were able to image im-
munoglobulin Fab' fragments by covalently linking Fab'
molecules to a lipid and incorporating them into a lipid
monolayer on the AFM substrate. Although imaging
was done under native conditions, extensive preparation
of the AFM surface was required, as well as chemical
modification of the Fab'. Furthermore, increases of the
applied force to above 10 nN pushed aside the proteins,
exposing only the lipid membrane.
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We describe here a means of anchoring protein mole-
cules for observation in AFM under native conditions
which employs a metal-chelating peptide. No labor-in-
tensive preparation oftheAFM surface or chemical mod-
ification of the protein is required. Addition of the
metal-chelating peptide to the IgG COOH-terminus al-
lows the COOH-terminal region of the protein to be an-
chored to the nickel-mica AFM substrate. As a result,
uniform orientation is achieved and the particular re-
gion of interest can be visualized. Furthermore, unlike
chemical modification, genetic engineering allows the
specific placement of the anchoring peptide to any de-
sired position on the molecule, so that other regions of
interest can be visualized. Orientation of molecules
under native conditions will also maximize the binding
of a second molecular species to a specific location on
the anchored species (5).
MATERIALS AND METHODS
Construction of IgG,-CP
Construction of the complete expression vector involved generating
four DNA fragments from a previously described gamma- I expression
vector called pNCEMG, (6). The first 9.0 kilobase fragment was gener-
ated using restriction enzymes Nru-I and Sal-I (GIBCO BRL, Gaith-
ersburg, MD) and contained the neomycin, beta-lactamase and heavy
chain variable region gene sequences. The second 1.8 kilobase frag-
ment was generated by PCR-amplifying (PCR kit was obtained from
Perkin Elmer Cetus, Norwalk, CT) the region ofpNCEMG, contain-
ing the constant region gene using an upstream primer that contained
30 base pairs of sense strand sequence 5' of the Sal- I site, and a down-
stream primer that contained 30 base pairs of the antisense strand, the
sequence coding for His-Trp-His-His-His-Pro, a stop codon, and Xma-
III site at its 5' end. Once amplified, this fragment was cloned into
pBR322 for confirmation ofthe desired nucleotide sequence. The third
324 base pair fragment was generated using an upstream primer that
contained at its 5' end the metal binding peptide sequence, stop codon,
Xma-III site, 30 base pairs ofsense strand sequence, and a downstream
primer that contained 30 base pairs of antisense sequence and the re-
striction site sequence for Nru- I at its 5' end. This fragment was needed
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to include the polyadenylation sequence and to overlap with the metal
binding peptide sequence in fragment 2. Overlapping or recombinant
PCR (7) was carried out for the generation of the final 2.1 kilobase
fragment. Fragment 4 was subcloned into a TA cloning vector (In
Vitrogen Corp., San Diego, CA) which contains single 3' deoxythy-
midylate overhangs and takes advantage of the terminal transferase
activity of thermophilic DNA polymerase, which adds a single 3'
deoxyadenylate residue to each end ofthe amplified fragment. Fr-4 was
isolated from the TA vector by a Sal- 1 / Nru- restriction enzyme digest
and ligated together with Fr- 1 to generate the 11.2 kilobase
pNCEMG,-CP.
PURIFICATION OF IgG1-CP FROM CHEL-13
SUPERNATANT
Concentrated culture supernatant from terminal cultures ofCHEL- 13
secreting cells grown in serum free media was dialyzed against Buffer A
(100 mM NaH2PO4, pH 7.4; 100 mM NaCl) at 4°C for 18 h. Follow-
ing dialysis the media was centrifuged at 3000 g for 10 min. The clari-
fied media was decanted and filtered through a 0.2 jm filter. A 2.1 x 30
mm iminodiacetate HPLC column from Perspective Biosystems was
loaded with Ni2+ according to the manufacturer's instructions. The
Ni 2+ loaded column was equilibrated with Buffer A on a Hewlett-Pack-
ard 1090 HPLC. Clarified media (5.0 ml) was injected onto the col-
umn at a flow rate of 1.0 ml/min. After the media was loaded, the
column was washed with 5.0 ml of Buffer A. The column was washed
successively with 5 ml 50% Buffer A; 50% Buffer B (100 mM
NaH2PO4, pH 4.25; 100 mM NaCl) then with 5.0 ml Buffer B. Follow-
ing these washes the column was re-equilibrated with 1.0 ml Buffer A.
Bound CHEL- 13 was eluted with a linear gradient from Buffer A to
Buffer C (1 M glycine, pH 8.7; 100 mM NaCl) developed over 10 min.
Fractions ( 1 min.) were collected and analyzed for antibody content by
SDS-PAGE (8). Residual bound nickel was removed from the IgG,-
CP by treatment with 10 mM EDTA in PBS. The EDTA was removed
from the antibody solution by concentrating the antibody in an Ami-
con cell with a YM- 10 membrane. The antibody was diluted in EDTA-
free PBS. This cycle of concentration and dilution was repeated until
the EDTA was diluted by a factor of 105.
ATOMIC FORCE MICROSCOPY OF IgG1 AND
IgGI-CP
Nickel-coated mica with IgG, and with IgG,-CP were imaged in a fluid
cell containing PBS (10 mM NaH2PO4, pH 7.0, 150 mM NaCI) at
room temperature. All images were obtained using a NanoScope II
atomic force microscope (Digital Instruments, Santa Barbara, CA) (9)
with a 12 ,um Scanner and a 120 ,um Si3N4 cantilever (K = 0.6 N/m).
Two-dimensional top views and 3-D views are 300 by 300 nm scale.
The freshly-cleaved mica surface was treated with 5 ml of 1 mM nickel-
chloride dissolved in MilliQ water for 1 min, rinsed three times with 1
ml of MilliQ water, and allowed to air dry. The IgG, or IgG,-CP were
diluted to a concentration of 0.5 jg/ml in PBS, injected into the fluid
cell, and allowed to interact with the nickel-mica surface for 10 min.
The fluid cell was then flushed with PBS and the images were collected.
The molecular dimensions were taken directly from the best multiple
images of individual molecules. The measurements are approximate
average dimensions of the diameter of the globular shaped antibodies.
The heights are average maximum thicknesses.
RESULTS AND DISCUSSION
In designing an IgG, with an added metal binding se-
quence it was necessary to modify the sequence in such a
way as to prevent disturbances to the functional and
structural portions of the native molecule. Inspection of
the human IgG, Fc crystal structure (10) revealed an
approximate 21 A distance between the COOH-terminal
residues of the two heavy chains.' The addition of the
metal binding sequence was thus not expected to inter-
fere with association of the heavy chains of the H2L2
IgG,-CP. A His-Trp-His-His-His- sequence was chosen
for its ability to bind tightly to a nickel or cobalt-loaded
metal affinity column ( 11). A proline was added to the
COOH-terminus to inhibit any potential processing of
the antibody by carboxypeptidases. For rapid site-di-
rected mutagenesis of the IgG, heavy chain gene the
cloning restriction sites and the 18 base pair metal bind-
ing peptide sequence were engineered into the primers of
three separate polymerase chain reactions (Fig. 1 A and
B). Overlapping or recombinant PCR (7) was carried
out for the generation of the final 2.1 kilobase fragment
(Fig. 1 B).
The pNCEMG,-CP heavy chain expression vector
was transfected by standard electroporation conditions
for mammalian cell gene expression ( 12-14) with modi-
fications to obtain the highest secreting clone ( 15). The
clone selected for the highest expression of intact anti-
body-CP (called chel- 13) expressed the complimentary
kappa light chain in excess ofthe intact antibody, i.e., 30
jug/ 106 cells of kappa light chain and 2.7 gg/ 106 cells of
intact antibody.
Supernatant containing IgGj-CP from high density
chel- 13 cultures grown in a serum-free medium formula-
tion (16) was purified by metal affinity HPLC yielding
the 4-peak chromatogram shown in Fig. 2. Fractions
from the peaks were analyzed by SDS-PAGE (Fig. 2 in-
set) and the proteins were identified as immunoglobulin
by western blotting with anti-human heavy chain and
anti-human light chain reagents (data not shown).
Some free kappa chain and kappa dimer was seen to
bind to the column. These chains eluted from the col-
umn at pH5.8 and pH4.25, respectively, and appear as
25 and 50 kD bands in the gel. The binding of these
chains was not quantitative as evidenced by the large
amount of free kappa and kappa dimer in the flow-
through fraction, suggesting that the binding is due to
endogenous His containing sequences that may not be
sterically accessible in all cases. IgGj-CP was eluted with
a glycine gradient. Glycine is known to strip the nickel
off of the column and the need for glycine to elute IgG,-
CP suggests that its affinity for nickel is relatively high.
IgG, without a COOH-terminal chelating peptide binds
weakly to the IMAC column (data not shown) presum-
ably through endogenous surface exposed histidines. Its
elution at pH 4.25 and inability to bind to nickel-coated
mica for atomic force microscopy (see below) suggested
lower affinity of the endogenous sequence. While the
absolute affinities of the unmodified IgG, versus the
' The molecular modeling system was from Silicon Graphics (Palo
Alto, CA) using Insight II software from Biosym (San Diego, CA).
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FIGURE I Cloning Scheme for pNCEMG,-CP: (A) The construction of the 17.6 kilobase chimeric expression vector pNCEMG 1 has been de-
scribed (6). Briefly, the expression vector contains the murine variable region of an anti-CEA murine heavy chain gene and the constant region
from a human IgG, gene. The neomycin and beta-lactimase genes are for mammalian and bacterial drug selection, respectively. A 9.0 kilobase
fragment 1 (Fr- I ) containing all but the human constant region gene was isolated from an Nru- 1 to Sal- 1 restriction enzyme digest without further
modification. The area of the vector marked with cross-hatches indicates approximately 5.5 kilobases of the 3' untranslated human gamma- 1 gene
sequence which was deleted as a result of the construction ofpNCEMGl-CP. (B) Three modified fragments, Fr-2, Fr-3, and Fr-4, were generated
from pNCEMG 1 (substrate) by the polymerase chain reaction as described in Materials and Methods. All site-directed mutations were achieved by
specific sequence addition to the 5' end ofthe primers. Fr-2 and the final 1 1.2 kilobase pNCEMG 1 -CP expression vector were confirmed to have the
desired His-Trp-His-His-His-Pro modification by DNA sequencing and PCR using a primer specific for this sequence addition.
IgGI-CP for nickel have not been determined, other stud-
ies have shown that elution profile and partition coeffi-
cients can be directly correlated with strength ofthe pro-
tein-metal interaction ( 17-19). We further demonstrate
the strength of the protein-metal interaction by direct
visualization of the IgG1-CP in a fluid cell by atomic
force microscopy.
Freshly cleaved mica produces a surface well-suited
for high resolution microscopy. It is known, however,
that proteins do not adhere well to mica and that anchor-
ing proteins to withstand the force of the atomic force
microscope stylus is a major hurdle for high resolution
imaging (3, 20, 21 ). Fig. 3 shows that by using the His-
Trp-His-His-His-Pro metal-binding sequence engi-
neered into the carboxy terminus of the antibody com-
bined with nickel treatment of the mica surface, stable
adherence and orientation of the IgGI was possible. Fig-
ure 3 a and 3 d are two images of freshly cleaved mica
coated with nickel chloride. Two dimensional Fourier
transform analysis of atomic scale images (data not
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FIGURE 2 Purification ofIgG,-CPfrom Chel-13 Supernatant: Chel- 13 containing cell culture media was processed and loaded onto a nickel-loaded
iminodiacetate column and bound proteins were eluted as described in Materials and Methods. The peaks are labeled with the buffer conditions
under which they eluted. The glycine gradient was begun at 28 min. Inset: SDS-PAGE Analysis ofFractions from the Iminodiacetate Column:
Aliquots ofthe CHEL- 13 containing media and fractions from the iminodiacetate column were separated on a 12% SDS-PAGE gel (8). Lanes 1-9
& 12; non-reducing, lanes 10 & 1 1; reducing. Lanes 1 & 12 high MW standards, lane 2; 40 ,ug CHEL-13 media, lane 3; 40 gg column flow through
fraction 4, lane 4; 3 jig fraction 13, lane 5; 2 Mg fraction 20, lane 6; 2 Mg fraction 31, lane 7; 2.5 Mg fraction 32, lane 8; 3.5 Mg fraction 33, lane 9; 4.5 ,ug
fraction 34, lane 10; 3.5 MAg fraction 33, lane 11; 4.5 Mg fraction 34. The arrow in lane 4 shows the absence of antibody in lane 3.
shown) of nickel-coated mica showed hexagonal sym-
metry plus high frequency peaks confirming nickel-
binding, ie., these were not present in mica alone. Fig. 3 b
and 3 e are images ofthe unmodified IgG, preincubated
with the nickel-coated mica at a concentration of 0.5
,g/ml. The force applied by the silicon nitride cantilever
was approximately 10-9'-0-'° Newtons. The pressure
beneath the tip is estimated to be 10 '-109 Pascal. The
large uncertainty in the applied force is in part caused by
the variability ofthe cantilever spring constant. The obvi-
ous smearing of the protein by the cantilever suggests
that the antibody is not tightly bound to this surface. Fig.
3 c and 3 fare images of the IgGI-CP preincubated on
the nickel-coated mica surface at a similar concentration
and in an identical manner as those in Fig. 3 b and 3 e.
All images are 300 by 300 nm areas. The globular struc-
tures imaged in Fig. 3 c and 3 fwere not displaced by the
cantilever using identical applied forces. (Applied forces
as high as l0- N were used with no apparent damage to
the IgGI-CP. Prolonged imaging (10 min), however,
and therefore prolonged forces, eventually scraped away
the antibody from the AFM substrate). Size determina-
tion showed them to be 14.0 nm in diameter by 3.4 nm
tall, which corresponds closely to IgG, dimensions deter-
mined by electron microscopic measurements and x-ray
diffraction (22, 23). Preincubation of the IgG1-CP with
a concentrated nickel chloride solution prevented tight
binding to the nickel-coated mica surface. In addition,
IgGj-CP did not bind tightly to mica that was not coated
with nickel chloride. The stability of the molecules rela-
tive to cantilever force, molecular dimensions, homoge-
neous appearance, and dependence on the interaction of
the metal binding sequence with nickel-coated mica, all
demonstrate the regiospecific orientation ofthe IgGj-CP
to this metal-bound surface.
CONCLUDING REMARKS
We have shown that an antibody molecule possessing an
engineered metal chelating peptide will bind to a metal
ion immobilized on an AFM substrate in a manner suffi-
ciently stable to resist the disrupting forces encountered
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during interaction with a mechanical entity such as an
AFM tip. By engineering the chelating peptide onto the
COOH-terminus ofthe antibody we were able to anchor
the antibody to the AFM substrate by a specific region of
the molecule, ensuring uniform orientation ofthe bound
antibody molecules. The binding of antibody to sub-
strate occurred under buffer conditions compatible with
the native conformation of the protein.
That the antibody image did not appear to be "Y" or
"T" shaped as one might expect may be explained by the
relatively blunt AFM tip. The silicon nitride cantilevers
have a gross tip radius ofapproximately 50 nm, however
the "roughness" of the tip is unknown and no one has
yet been able to measure the lowest point of the tip,
which is thought to be the effective tip. In future studies
it will be of interest to try oxide sharpened Si3N4 tips or
"super tips" (2). It is also a possibility that in the PBS
solution, the antibody would not adopt a rigid confor-
mation that would be required in order for the character-
istic "Y" or "T" shape to be seen.
Anchoring the antibody by its COOH-terminus
should maximize the exposure of the combining site
(which is comprised of the NH2-terminal portion of the
protein) as has been observed to occur in antibody affin-
ity columns (5). Additionally, by anchoring the protein
under non-denaturing conditions it should retain its bio-
logical activity. Anchored, oriented, active antibody
should provide a system well suited for the examination
ofreal-time antigen-antibody interactions by direct visu-
alization by AFM. Future developments in this area
should strengthen AFM as a technique complimentary
to the other biochemical and biophysical techniques
currently used to examine protein structure and func-
tion.
Receivedfor publication 14 September 1992 and in finalform
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